244 related articles for article (PubMed ID: 6474644)
1. Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder.
Gorelick JI; Oyasu R; Golmon ME; Grayhack JT
Urology; 1984 Sep; 24(3):287-90. PubMed ID: 6474644
[TBL] [Abstract][Full Text] [Related]
2. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
Das G; Glashan RW
J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
[TBL] [Abstract][Full Text] [Related]
3. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
[TBL] [Abstract][Full Text] [Related]
4. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer.
Das G; Buxton NJ; Stewart PA; Glashan RW
J Urol; 1986 Dec; 136(6):1194-6. PubMed ID: 3534312
[TBL] [Abstract][Full Text] [Related]
6. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
7. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
[TBL] [Abstract][Full Text] [Related]
9. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
Kumon H; Nasu Y; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
[No Abstract] [Full Text] [Related]
10. [The BTA stat test in the follow-up for bladder cancer].
Gutiérrez Baños JL; Martín García B; de Diego Rodríguez E; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; Rado Velázquez MA
Arch Esp Urol; 1999 Oct; 52(8):856-61. PubMed ID: 10589117
[TBL] [Abstract][Full Text] [Related]
11. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
[TBL] [Abstract][Full Text] [Related]
12. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
[TBL] [Abstract][Full Text] [Related]
13. Cytohistological study of urinary bladder neoplasms.
Misra V; Gupta SC; Tandon SP; Gupta AK; Sircar S
Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
[TBL] [Abstract][Full Text] [Related]
14. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
15. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
[No Abstract] [Full Text] [Related]
16. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
Borella T; Loro M; Dato I; Merlo F; Giudici M
Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of urinary cytology in patients with bladder carcinoma.
Schoonees R; Gamarra MG; Moore RH; Murphy GP
J Urol; 1971 Nov; 106(5):693-6. PubMed ID: 5115726
[No Abstract] [Full Text] [Related]
18. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
Konety BR; Metro MJ; Melham MF; Salup RR
Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
[TBL] [Abstract][Full Text] [Related]
19. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
